About Genavli
Genavli is a Healthcare company based in Solapur (India) founded in 2017 by Avinash Abhyankar. It develops innovative technologies for whole genome sequencing assays. It operates on a B2B model. Its chief executive is Avinash Abhyankar. Its focus areas include Biotechnology, Genomics and Sequencing Assays. Its legal entity in India is Genavli Biotech Private Limited (U85100PN2017PTC173966). Its competitors include InformedDNA, MyOme, Dante Labs, Answer Genomics and ARQUIMEA INGENIERIA and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
Genavli, based in Solapur, focuses on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and sequencing assays. Develops innovative technologies for whole genome sequencing assays. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Solapur, India
- Founders Avinash Abhyankar
- SectorsHealthcare
- Website genavli.in
- Social X Facebook
- Legal Name Genavli Biotech Private Limited
- Date of Incorporation 21 Dec, 2017
- Jurisdiction Solapur, Maharashtra, India
- Net Loss-₹2.4 Lakh
FY 2022 · 0% margin
- EBITDA-₹1.9 Lakh
FY 2022 · 0% margin
Associated legal entities of Genavli
Genavli operates through Genavli Biotech Private Limited (under process of striking off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genavli Biotech Private Limited CIN U85100PN2017PTC173966 | Under Process Of Striking Off | 21 Dec 2017 | Solapur, Maharashtra | – | – | 2 | View details |
Board of directors of Genavli Biotech Private Limited (Genavli)
Genavli Biotech Private Limited is the primary company behind Genavli. The board of Genavli Biotech Private Limited currently have 2 directors; the longest-serving is Gurunath Shankarappa Wachche, appointed in 2017. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gurunath Shankarappa Wachche DIN 01104180 | Director | 21 Dec 2017 | 8 yrs 9 mo | Genavli Biotech Private Limited |
| Suresh Dharma Rathod DIN 08689148 | Director | 22 Jun 2021 | 5 yrs 3 mo | Genavli Biotech Private Limited |
People of Genavli
1 people are tracked at Genavli (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership |
Complete people profiles for Genavli
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Genavli
Figures of Genavli Biotech Private Limited, the primary company behind Genavli, for FY 2022. Net loss was -₹2.4 Lakh (0% margin). EBITDA was -₹1.9 Lakh (0% margin).
- -₹2.4 LakhNet loss · 0% margin
- -₹1.9 LakhEBITDA · 0% margin
- ₹3.5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Genavli Biotech Private Limited are on its company page.
Detailed financial statements for Genavli
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Genavli
Genavli has 10 listed competitors in our database, 6 of them funded. They include InformedDNA, MyOme, Dante Labs, Answer Genomics and ARQUIMEA INGENIERIA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| informeddna.com | 2007 | St Petersburg, United States | $19.22M | – | Network of genetics experts provided to assist patients and providers. | |
| myome.com | 2017 | San Carlos, United States | $23M | – | Provider of a platform for gene analysis to determine genetic diseases and drug response | |
| dantelabs.com | 2016 | New York, United States | – | – | Whole-genome sequencing analysis is offered for health and wellness insights. | |
| answergenomics.in | 2018 | Bengaluru, India | $534,256 | 1 | Online platform offering DNA-based recommendations for health and wellness | |
| arquimea.com | 2005 | Madrid, Spain | – | – | Provider of engineering, manufacturing, and research and development services to industries | |
| selfdecode.com | 2016 | San Luis Obispo, United States | $8M | 4 | Personal genome data is analyzed for health and wellness reports. | |
| pwnhealth.com | 2015 | New York, United States | – | – | Population health and clinical genomic screening solutions are provided. | |
| canomiks.com | 2016 | Cambridge, United States | – | – | Provider of dietary supplements and functional food based on genomic analysis | |
| arivale.com | 2014 | Seattle, United States | $49.6M | – | Provider of direct-to-consumer genetic testing. | |
| 3x4genetics.com | 2018 | Cape Town, South Africa | $2.5M | – | Genetic tests for health diagnostics are developed using DNA samples. |
Detailed competitors of Genavli
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Genomics
10 companies that operate in the same segment as Genavli (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | USD 812.03 M | 61 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genavli
Genavli was founded in 2017.
Genavli is headquartered in Solapur, India. It is registered at Solapur, Maharashtra, India.
Avinash Abhyankar is the current CEO of Genavli. They have also founded this company.
Genavli, based in Solapur, focuses on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and sequencing assays. Develops innovative technologies for whole genome sequencing assays. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Genavli's top competitors include Dante Labs, InformedDNA and MyOme.
Genavli operates through Genavli Biotech Private Limited.
The legal entities of Genavli currently have 2 directors, including Gurunath Shankarappa Wachche, Suresh Dharma Rathod.